Science

Scientists Achieve Breakthrough in Oral Insulin Development Using Revolutionary Peptide Platform

Kumamoto University researchers develop system that could finally replace daily injections with pills for diabetes patients worldwide.

· 2 min read
Scientists Achieve Breakthrough in Oral Insulin Development Using Revolutionary Peptide Platform

For more than 100 years, scientists have pursued the idea of insulin in pill form, often described as a "dream" treatment for diabetes. The challenge has been the body itself. Enzymes in the digestive system break down insulin before it can work, and the intestine lacks a natural way to absorb it into the bloodstream. As a result, many patients still depend on daily injections, which can take a toll on their quality of life.

A team at Kumamoto University, led by Associate Professor Shingo Ito, has now developed a promising solution. Their approach uses a cyclic peptide that can pass through the small intestine, known as the DNP peptide. This platform allows insulin to be delivered orally in a way that was not previously possible.

Two Effective Strategies for Intestinal Absorption

To make this work, the researchers designed two different methods to help insulin cross the intestinal barrier:

Lower Doses Make Oral Insulin More Practical

One of the biggest obstacles for oral insulin has been the need for extremely high doses, sometimes more than ten times higher than injections. This new platform significantly reduces that requirement. It achieved a pharmacological bioavailability of about 33-41% compared to subcutaneous injection. That level of efficiency suggests oral insulin could become far more practical for real-world use.

Future Potential for Diabetes Treatment

"Insulin injections remain a daily burden for many patients," said Associate Professor Shingo Ito. "Our peptide-based platform offers a new route to deliver insulin orally and may be applicable to long-acting insulin formulations and other injectable biologics."

The findings were published in the journal Molecular Pharmaceutics. The researchers are now moving forward with additional studies, including testing in larger animal models and systems that replicate the human intestine, as they work toward eventual clinical applications.

Materials provided by Kumamoto University. Note: Content may be edited for style and length.

New Study Reveals Hidden Trade-Off in Popular Weight Loss Treatments

AI Uncovers Hidden Signals, Discovering Dozens of New Alien Planets

Scientists "Bottle the Sun" With Revolutionary Liquid Battery

This Ancient Ape Fossil Could Change Where Humans Came From

Originally reported by ScienceDaily Top.

diabetes insulin oral medication peptides medical research drug delivery